Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
Company Description (as filed with the SEC)
Flamel Technologies SA is a specialty pharmaceutical company utilizing core competencies in drug delivery and formulation to develop safer and more efficacious pharmaceutical products to address unmet medical needs and/or reduce overall healthcare costs. The Company has a balanced business model consisting of a successful previously Unapproved Marketed Drugs ("UMDs") business with two approved and marketed products in the USA, Bloxiverz® (neostigmine methylsulfate injection) and Vazculep(TM) (phenylephrine hydrochloride injection), both obtained through the acquisition of Éclat Pharmaceuticals, LLC's (or "Éclat") portfolio on March 13, 2012, and a branded business, focusing on the development of products utilizing Flamel's proprietary drug delivery platforms. ... More ...
Where does FLML fit in the risk graph?
|Annual EPS Est:||$-0.56|
|Quarterly EPS Est:||0.35|